文献速递前列腺增生与排尿功能障碍前列腺癌

计算机视觉检测度他雄胺对良性前列腺的细微组织学效应

Computer vision detects subtle histological effects of dutasteride on benign prostate.
PubMed 文献 · BJU Int · 2018-03-25

本研究纳入REDUCE试验中100例无前列腺癌且坚持治疗的男性,比较度他雄胺与安慰剂组前列腺活检H&E图像。病理学家盲法评分判别准确性仅相当于随机水平,而21特征计算机视觉模型在第4年活检交叉验证AUC达0.97(95%CI 0.95-0.99),第2年独立验证AUC为0.79(95%CI 0.65-0.92)。

要点

  • 计算机视觉模型可区分度他雄胺治疗组织与安慰剂,第4年活检AUC 0.97。
  • 病理学家盲法评分对度他雄胺治疗组织的判别准确性仅相当于随机水平。
  • 组织学评分与PSA变化、血清DHT水平或腺体体积不相关。

核心结论

  • 计算机视觉方法可检测度他雄胺所致的细微组织学效应,并形成对药物反应性的连续度量。

研究设计与样本

  • 研究纳入REDUCE试验中100例无前列腺癌且坚持治疗的男性,随机分配至度他雄胺或安慰剂组,均有第4年强制活检切片,其中一半还有第2年活检切片。
  • 采用惩罚逻辑回归和五折交叉验证在第4年活检中寻找组织学特征的最佳组合,并将第2年活检特征数据拟合至最终模型进行独立验证。
  • 两名对治疗分组不知情的病理学家对每张图像进行局灶性萎缩及既往与5ARI治疗相关组织学特征的评分。

主要发现

  • 病理学家共识分类的判别准确性仅相当于随机水平。
  • 21特征计算机视觉模型在第4年活检中的交叉验证AUC为0.97(95%CI 0.95-0.99),在第2年独立验证集中的AUC为0.79(95%CI 0.65-0.92)。
  • 组织学评分与前列腺特异性抗原水平变化、血清双氢睾酮水平或腺体体积均不相关。
  • 与度他雄胺治疗相关的关键特征包括间质形状和颜色更均匀、上皮细胞核不规则聚集以及管腔形状变异更大。

临床怎么用

  • 计算机视觉方法有望用于预测BPH治疗或癌症化学预防中个体患者对5ARI的反应性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether a computer vision-based approach applied to haematoxylin and eosin (H&E) prostate biopsy images can distinguish dutasteride-treated tissue from placebo, and identify features associated with degree of responsiveness to 5α-reductase inhibitor (5ARI) therapy. SUBJECTS AND METHODS: Our study population comprised 100 treatment-adherent men without prostate cancer assigned to dutasteride or placebo in the REDUCE trial, who had slides available from mandatory year-4 biopsies. Half of the men also provided slides from a year-2 biopsy. We obtained 20× whole-slide images and used specialized software to generate a library of 1 300 epithelial and stromal features from objects comprising superpixels and several types of nuclei, including spatial relations among objects between and within each hierarchical level. We used penalized logistic regression and fivefold cross-validation to find optimal combinations of histological features in the year-4 biopsies. Feature data from the year-2 biopsies were fitted to a final model for independent validation. Two pathologists, blinded to treatment, scored each image for focal atrophy and histological features previously linked to 5AR1 treatment. RESULTS: Consensus classification by pathologists obtained a discrimination accuracy equivalent to chance. A 21-feature computer vision model gave a cross-validation area under the curve of 0.97 (95% confidence interval [CI] 0.95-0.99) in the year-4 biopsies and 0.79 (95% CI: 0.65-0.92) in the set-aside year-2 biopsies. Histology scores were not correlated with change in prostate-specific antigen level, serum dihydrotestosterone level or gland volume. Key features associated with dutasteride treatment included greater shape and colour uniformity in stroma, irregular clustering of epithelial nuclei, and greater variation in lumen shape. CONCLUSION: The present findings show that a computer vision approach can detect subtle histological effects attributable to dutasteride, resulting in a continuous measure of responsiveness to the drug that could eventually be used to predict individual patient response in the context of BPH treatment or cancer chemoprevention.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Sethi A, Sha L, Kumar N, et al. Computer vision detects subtle histological effects of dutasteride on benign prostate. BJU Int. 2018. PMID: 29461667. doi:10.1111/bju.14172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。